a public good project by the
Synthesis
Company
of California

© 2026

Gong Yang | doi.page

0 works0 citations0 h-index

Gong Yang

Shanghai Jiao Tong University(CN)Sahlgrenska University Hospital(SE)Wuhan University(CN)Renmin Hospital of Wuhan University(CN)University of Gothenburg(SE)

Publications by Year

Research Areas

Cancer-related Molecular Pathways, Cancer-related molecular mechanisms research, Microtubule and mitosis dynamics, Ovarian cancer diagnosis and treatment, MicroRNA in disease regulation

Most-Cited Works

→ The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis(2006)335 cited
→ A Genetically Defined Model for Human Ovarian Cancer(2004)273 cited
→ Mitochondrial Manganese-Superoxide Dismutase Expression in Ovarian Cancer(2005)272 cited
→ CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis(2010)189 cited
→ FOXP1 controls mesenchymal stem cell commitment and senescence during skeletal aging(2017)183 cited
→ Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy(2019)162 cited

→ HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy(2006)

160 cited

→ The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy(2019)145 cited

→ The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis(2006)135 cited

→ Activation of Antioxidant Pathways in Ras-Mediated Oncogenic Transformation of Human Surface Ovarian Epithelial Cells Revealed by Functional Proteomics and Mass Spectrometry(2004)134 cited